Individualised (177)Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

PURPOSE: To present data from an interim analysis of a Phase II trial designed to determine the feasibility, safety, and efficacy of individualising treatment based on renal dosimetry, by giving as many cycles as possible within a maximum renal biologically effective dose (BED). METHOD: Treatment wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundlöv, Anna, Sjögreen-Gleisner, Katarina, Svensson, Johanna, Ljungberg, Michael, Olsson, Tomas, Bernhardt, Peter, Tennvall, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506097/
https://www.ncbi.nlm.nih.gov/pubmed/28331954
http://dx.doi.org/10.1007/s00259-017-3678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506097/
https://www.ncbi.nlm.nih.gov/pubmed/28331954
http://dx.doi.org/10.1007/s00259-017-3678-4

Ejemplares similares